跳至主要内容
临床试验/NCT05324202
NCT05324202Unknown不适用

New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma

Dr. Stephanie Geisler0 个研究点目标入组 50 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
主要终点
Treatment efficacy of Nd:YAG Laser 1064-nm for low risk basal cell carcinomas

研究概览

简要总结

The aim of this study is to show that the Nd:YAG laser could be a promising alternative treatment option in the management of low-risk basal cell carcinomas with similar high efficacy rates to surgery, and low recurrence rates evaluated over a time period of one year. Reflectance confocal microscopy, optical coherence tomography and clinical examination are used prior to confirm the clinical diagnosis of the basal cell carcinoma and for premargination of the tumor. The optical coherence tomography will also be used post treatment to confirm clearance of the basal cell carcinoma and to monitor treatment response.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with one or more basal cell carcinoma(s) on head, trunk or extremities
  • Diagnosed clinically, with a dermatoscope and through noninvasive imaging methods such as reflectance confocal microscopy and optical coherence tomography
  • H zone <6mm, M zone <10mm, L zone <20mm
  • Tumor thickness <2mm
  • Clearly visible margins

排除标准

  • Pregnancy
  • <18 years of age
  • Current or history of immunosuppression
  • Prior-treatment of the basal cell carcinoma/ recurrent basal cell carcinomas
  • History of radiation in the area of basal cell carcinoma appearance

结局指标

主要结局

Treatment efficacy of Nd:YAG Laser 1064-nm for low risk basal cell carcinomas

时间窗: 8 weeks after the treatment

Clearance rate of basal cell carcinomas after 1-3 Nd:YAG laser treatments evaluated by clinical inspectation, dermatosopy and optical coherence tomography.

Recurrence Rate after Nd:YAG Laser treatment

时间窗: 12 months

To assess the recurrence rate after a long-term follow-up of 6 and 12 months

次要结局

  • Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability)(6 and 12 months after treatment)
  • Cosmetic outcome after laser treatment(6 and 12 months after treatment)

研究者

发起方
Dr. Stephanie Geisler
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Stephanie Geisler

Investigator, Resident in Dermatology

Medical University of Vienna

相似试验